Search results for "MULTIFOCAL"

showing 10 items of 106 documents

Redzes funkciju izvērtējums pacientiem agrīnā presbiopijas vecumā ar vienas dienas multifokālajām kontaktlēcām

2017

Bakalaura darbs uzrakstīts uz 27 lapaspusēm, satur 18 zīmējumus, 1 tabulu un 20 literatūras avotus. Darba mērķis ir novērtēt redzes asumu un kontrasta jūtību fotopiskos un mezopiskos apstākļos pacientiem, koriģētiem ar brillēm un vienas dienas multifokālajām kontaktlēcām. Mūsu pētījumi parādīja, ka fotopiskos apstākļos pacientiem pēc korekcijas ar multifokālajām kontaktlēcām redzes asums vidēji samazinājās par 0,02 logMAR vienībām. Mezopiskos krēslas apstākļos pacientiem koriģētiem ar multifokālajām kontaktlēcām redzes asuma samazinājums vidēji bija 0.05 logMAR vienības. Atšķirības redzes asumā ir statistiski nozīmīgas. Kontrasta jūtības vidējie lielumi pēc kontaktlēcu uzlikšanas vidēji sam…

contrast sensitivityphotopic conditionpresbyopia correctionmesopic conditionOptometrijamultifocal contact lenses
researchProduct

Hiperplasia multifocal del epitelio: Reporte de nueve casos

2005

La hiperplasia multifocal del epitelio (HME) conocida también como hiperplasia epitelial focal, enfermedad de Heck ó hiperplasia multifocal del epitelio por papiloma virus, se caracteriza por la aparición de lesiones múltiples en la mucosa de la cavidad bucal en población pediátrica y se asocia a la presencia del virus papiloma humano. El objetivo de este estudio fue conocer las características clínico-patológicas de los casos diagnosticados de esta enfermedad en el Servicio de Dermatología del Hospital Manuel Gea González. Se revisaron los archivos de esta institución y se seleccionaron los casos diagnosticados como HME. Se encontraron 9 casos. La mayoría de los pacientes fueron menores de…

enfermedad de Heckpapilomavirus humanoUNESCO::CIENCIAS MÉDICASHiperplasia multifocal del epitelioOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la salud
researchProduct

Subjective photic phenomena with refractive multifocal and monofocal intraocular lenses. results of a multicenter questionnaire.

2001

Abstract Purpose To compare the incidence and severity of photic phenomena after the implantation of the Array® (Allergan) refractive multifocal intraocular lens (MIOL) and a monofocal IOL. Setting Multicenter study at Kiel, Mainz, Karlsruhe, and Bremerhaven, Germany. Methods The study comprised 231 randomly selected patients from 4 study centers. The patients had had uneventful phacoemulsification with implantation of a refractive MIOL (n = 138) or a monofocal IOL (n = 93). By questionnaire, patients were asked whether they experienced light sensations postoperatively (light streaks, halos, flare, flashes, or glare) that had not been noticed preoperatively. Additional questions evaluated w…

genetic structuresLightmedicine.medical_treatmentEye diseaseVision DisordersIntraocular lensGlareVision disorderLens Implantation IntraocularSurveys and QuestionnairesmedicineHumansLenses IntraocularPhacoemulsificationbusiness.industryIncidenceGlare (vision)PhacoemulsificationMultifocal intraocular lensCataract surgerymedicine.diseaseeye diseasesSensory SystemsOphthalmologyMulticenter studyOptometrySurgerysense organsmedicine.symptombusinessJournal of cataract and refractive surgery
researchProduct

Modulation transfer function in refractive-diffractive multifocal intraocular lenses in vitro

2007

Purpose: The optical quality of two types of multifocal, hybrid refractive-diffractive, intraocular lenses (IOL) is analyzed in vitro. Following the EN-ISO international standard, the IOLs’ modulation transfer functions (MTF) are determined for both distance and near vision. The behaviour of these curves when the pupil size varies is studied. Methods: The IOLs analyzed were: AcrySoft ResTor SN60D3 (Alcon) and Tecnis ZM900 (AMO). The MTF was calculated from the cross line-spread function recorded with the OPAL Vector System (Image Science Ltd. Oxford) by using fast Fourier transform techniques. The artificial eye model used simulates in vivo conditions of the anterior chamber including an ar…

genetic structuresbusiness.industryImage qualityStrehl ratioMultifocal intraocular lenseye diseasesPupilOptical qualityOphthalmologyOpticsIntraocular lensesOptical transfer functionMedicinesense organsImaging sciencebusinessActa Ophthalmologica Scandinavica
researchProduct

Multifokale Intraokularlinsen

2001

Modern cataract surgery has developed tremendously during the past 10-15 years. Improved surgical techniques, as well as improved implant materials and designs, have enlarged patient profiles and indications for cataract surgery. This also created much higher expectations from the patients' site. The loss of accommodation is loss of quality of life for presbyopic and especially young pseudophakic patients. Therefore cataract surgery with multifocal IOL implantation is not only of academic interest, but reflects demands and expectations of our patients. Multifocal IOLs have been implanted since 1986, starting with 2-3 zone refractive and diffractive designs. Due to surgical techniques of tha…

genetic structuresmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentEye diseaseGlare (vision)Intraocular lensCataract surgeryCorneal topographymedicine.diseaseAphakiaeye diseasesOphthalmologymedicineOptometryMultifocal IOLssense organsImplantbusinessDer Ophthalmologe
researchProduct

Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab

2015

International audience; Natalizumab (NTZ), a monoclonal antibody recognizing the alpha4 integrin chain, has been approved for the treatment of active multiple sclerosis, but expose to the onset of a rare side effect, progressive multifocal leukoencephalopathy (PML). Estimating the individual risk of PML in NTZ-treated patients is a major challenge, and therapeutic strategies are mainly guided by the overall PML risk assessed by identified risk factors: JC virus (JCV) seropositivity, treatment duration (with peak incidence after 24 months), and the previous use of immunosuppressive therapies. Given that this stratification does not yet allow a precise individual prediction of PML, other pred…

lcsh:Immunologic diseases. Allergy[SDV.IMM] Life Sciences [q-bio]/ImmunologySide effectmedicine.drug_classvirusesImmunologyJC virusReview Articlerisk stratificationCD11aJC virusmultiple sclerosismedicine.disease_causeMonoclonal antibodyCD49dprogressive multifocal leukoencephalopathyNatalizumabeffector memory T-cellst effector memory cellsImmunology and AllergyMedicineselectinPMLbusiness.industryMultiple sclerosisProgressive multifocal leukoencephalopathyvirus diseasesmedicine.disease3. Good healthJCVImmunologySelectins[SDV.IMM]Life Sciences [q-bio]/Immunologylcsh:RC581-607businessmedicine.drugFrontiers in Immunology
researchProduct

Chirurgia refrattiva della cataratta e lenti multifocali

2010

lenti multifocalichirurgia refrattivaSettore MED/30 - Malattie Apparato Visivocataratta
researchProduct

CT and MR Imaging of Non-neoplastic Intracranial Masses

1989

Many intracranial mass lesions of non-neoplastic origin present CT and MR features similar or identical to those of true neoplasms. In many cases a definitive diagnosis cannot be made from imaging findings alone, and misinterpretation is possible even when the history and clinical findings are considered. Yet an accurate preoperative diagnosis is an essential prerequisite for selecting candidates for a neurosurgical operation and planning the procedure. In some cases the full range of neuroradiologic techniques may have to be applied and evaluated in the context of clinical findings before the physician can accurately classify the disease and draw appropriate therapeutic conclusions.

medicine.medical_specialtyNon neoplasticbusiness.industryProgressive multifocal leukoencephalopathyPrimary central nervous system lymphomaContext (language use)medicine.diseaseMr imagingArachnoid cystmedicineRadiologybusinessBrain abscessIntracranial mass
researchProduct

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Reading ability with 3 multifocal intraocular lens models.

2006

Purpose To prospectively evaluate reading performance with of 3 types of multifocal intraocular lenses (IOLs) under different lighting conditions based on reading acuity and reading speed tests. Setting Augenklinik, Bad Hersfeld, Germany. Methods This randomized study comprised 60 cataract patients (120 eyes) randomly assigned to receive an SA40N IOL (AMO) (Group 1, 20 patients), Tecnis ZM001 IOL (AMO) (Group 2, 20 patients), or AcrySof ReSTOR SA60D3 IOL (Alcon) (Group 3, 20 patients). Pupil size and reading ability at near (visual acuity, reading speed) without correction, with best distance correction, and with best near correction were assessed 6 weeks postoperatively under low-light con…

medicine.medical_specialtyVisual acuitygenetic structuresLightPseudophakiamedicine.medical_treatmentmedia_common.quotation_subjectEye diseaseVisual AcuityIntraocular lensContrast SensitivityLens Implantation IntraocularOphthalmologyReading (process)medicineHumansProspective Studiesmedia_commonLenses IntraocularPhacoemulsificationbusiness.industrySignificant differencePupil sizePupilMultifocal intraocular lensMiddle Agedmedicine.diseaseDistance correctioneye diseasesSensory SystemsOphthalmologyReadingOptometrySurgerysense organsmedicine.symptombusinessJournal of cataract and refractive surgery
researchProduct